Table 1.
Distribution of congenital heart disease in patients
| Sort | Gender | Total (%) | |
|---|---|---|---|
|
| |||
| Male | Female | ||
| VSD | 5 | 8 | 13 (18.6) |
| ASD | 8 | 18 | 26 (37.1) |
| PFO | 3 | 3 | 6 (8.6) |
| TOF | 2 | 3 | 5 (7.1) |
| PDA | 0 | 4 | 4 (5.7) |
| VSD+ASD | 2 | 1 | 3 (4.3) |
| VSD+PFO | 1 | 1 | 2 (2.6) |
| ASD+PDA | 0 | 1 | 1 (1.4) |
| ASD+PFO | 1 | 0 | 1 (1.4) |
| RVOTS | 0 | 1 | 1 (1.4) |
| TECD | 1 | 0 | 1 (1.4) |
| TI | 1 | 0 | 1 (1.4) |
| BAV | 2 | 0 | 2 (2.6) |
| HCM | 1 | 0 | 1 (1.4) |
| PLSVC | 1 | 0 | 1 (1.4) |
| Else | 1 | 1 | 2 (2.6) |
| Total | 29 | 41 | 70 (100) |
PFO, patent foramen ovale; TOF, tetralogy of Fallot; PDA, patent ductus arteriosus; RVOTS, right ventricular outflow tract septum; TECD, complete type endocardial cushion defect; TI, tricuspid insufficiency; BAV, bicuspid aortic valve; HCM, hypertrophic cardiomyopathy; PLSVC, persistent left superior vena cava.